SCHEMBL24313736

SCHEMBL24313736

O=C(O)c1cc2c(-n3ccnc3)cc(C3CC3)cc2o1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TBXAS1 P24557 2/20 0.39
NSD2 O96028 1/20 0.38
PIM1 P11309 2/20 0.35
CSNK2A1 P68400 2/20 0.35
CSNK2A2 P19784 1/20 0.35
CSNK2B P67870 1/20 0.35
CSNK2A3 Q8NEV1 1/20 0.35
HTR2A P28223 1/20 0.34
HTR2C P28335 1/20 0.34
HTR2B P41595 1/20 0.34
NAPEPLD Q6IQ20 1/20 0.33
MCL1 Q07820 1/20 0.33
ADH5 P11766 1/20 0.33
TBK1 Q9UHD2 2/20 0.32
HSP90AA1 P07900 1/20 0.32
ABCB1 P08183 1/20 0.32
CYP3A4 P08684 1/20 0.32
CYP2C8 P10632 1/20 0.32
CYP2D6 P10635 1/20 0.32
CYP2C9 P11712 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29588188 1.00 TBXAS1 (0.39) TBXAS1NSD2PIM1CSNK2A1CSNK2A2
SCHEMBL29588133 0.73 ABCB1 (0.37) ABCB1CYP3A4CYP2C8CYP2D6CYP2C9
SCHEMBL24313941 0.73 ABCB1 (0.37) NSD2NAPEPLDABCB1CYP3A4CYP2C8
SCHEMBL24314181 0.72 MCL1 (0.41) PIM1CSNK2A1CSNK2A2CSNK2BCSNK2A3
SCHEMBL25192493 0.70 CD38 (0.41) HTR2AHTR2CHTR2BNAPEPLDADH5
SCHEMBL31005858 0.70 CD38 (0.41) HTR2AHTR2CHTR2BNAPEPLDADH5
SCHEMBL29587761 0.69 MCL1 (0.42) PIM1CSNK2A1CSNK2A2CSNK2BCSNK2A3
SCHEMBL24313929 0.69 MCL1 (0.38) PIM1CSNK2A1CSNK2A2CSNK2BCSNK2A3
SCHEMBL24313926 0.69 MCL1 (0.42) PIM1CSNK2A1CSNK2A2CSNK2BCSNK2A3
SCHEMBL29749433 0.68 MAP3K5 (0.38)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022081842-A1 SUBSTITUTED ACYL SULFONAMIDES FOR TREATING CANCER THE BROAD INSTITUTE, INC. (US) 2022-04-21 WO disclosed